MATLIN DAVID J — SEC insider filings
SEC reporting owner CIK 1251956. 65 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers the 50 most recent of 65 filings on record, filed 2021-11-17 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 26 legs across 18 filings — 5,752,929 shares, $7,728,092 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: purchase of 2,871,287 shares @ $1.01 ($2,900,000) in Clene Inc., filed 2022-11-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Clene Inc. (CLNN) | Director | 41 | 26 legs · 5,752,929 sh · $7,728,092 | — | 35 |
| TriSalus Life Sciences, Inc. (TLSI) | Director | 8 | — | — | 15 |
| U.S. WELL SERVICES, INC. (USWS) | Director | 1 | — | — | 1 |
Insider filings — MATLIN DAVID J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Clene Inc. (CLNN) | Grant/award (A): 6,019 (derivative) @ $0 | EDGAR |
| 2026-09-18 | 4 | Clene Inc. (CLNN) | Grant/award (A): 434,451 @ $3.28 | EDGAR |
| 2026-08-14 | 4 | Clene Inc. (CLNN) | Grant/award (A): 6,230 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Clene Inc. (CLNN) | Grant/award (A): 1,500 (derivative) @ $0 · Grant/award (A): 3,659 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 28,201 @ $0 · Grant/award (A): 23,065 @ $0 · Grant/award (A): 56,403 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Conversion (C): 330,000 @ $0 · Conversion (C): 100,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Clene Inc. (CLNN) | Grant/award (A): 5,372 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Clene Inc. (CLNN) | Purchase (P): 33,333 @ $6.50 · Grant/award (A): 40,000 (derivative) · Grant/award (A): 93,333 (derivative) | EDGAR |
| 2025-11-14 | 4 | Clene Inc. (CLNN) | Grant/award (A): 3,692 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | Clene Inc. (CLNN) | Grant/award (A): 7,255 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Clene Inc. (CLNN) | Grant/award (A): 10,209 (derivative) @ $0 · Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | Clene Inc. (CLNN) | Grant/award (A): 5,628 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Other (J): 89,501 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 10,040 @ $0 | EDGAR |
| 2024-12-09 | 4 | Clene Inc. (CLNN) | Grant/award (A): 5,563 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Clene Inc. (CLNN) | Grant/award (A): 4,990 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Clene Inc. (CLNN) | Purchase (P): 92,307 @ $4.75 · Grant/award (A): 92,307 (derivative) @ $0.12 | EDGAR |
| 2024-08-21 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Clene Inc. (CLNN) | Grant/award (A): 65,723 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Clene Inc. (CLNN) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Clene Inc. (CLNN) | Grant/award (A): 57,488 (derivative) @ $0 | EDGAR |
| 2023-11-29 | 4 | Clene Inc. (CLNN) | Grant/award (A): 56,024 (derivative) @ $0 | EDGAR |
| 2023-11-13 | 4 | Clene Inc. (CLNN) | Purchase (P): 250,002 @ $0.41 | EDGAR |
| 2023-09-19 | 4 | Clene Inc. (CLNN) | Grant/award (A): 46,659 (derivative) @ $0 | EDGAR |
| 2023-08-14 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Other (J): 931,904 · Other (J): 1,240,518 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $10 | EDGAR |
| 2023-06-27 | 4 | MedTech Acquisition Corp (MTAC) jointly with MedTech Acquisition Sponsor LLC, Dewey Christopher C | Conversion (C): 6,249,999 · Conversion (C): 6,249,999 (derivative) | EDGAR |
| 2023-06-20 | 4 | Clene Inc. (CLNN) | Purchase (P): 1,500,000 @ $0.80 · Grant/award (A): 1,500,000 (derivative) · Grant/award (A): 1,500,000 (derivative) | EDGAR |
| 2023-05-05 | 4 | Clene Inc. (CLNN) | Grant/award (A): 27,628 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-02-03 | 4 | Clene Inc. (CLNN) | Grant/award (A): 15,894 (derivative) @ $0 | EDGAR |
| 2022-11-04 | 4 | Clene Inc. (CLNN) | Grant/award (A): 21,476 (derivative) @ $0 | EDGAR |
| 2022-11-03 | 4 | Clene Inc. (CLNN) | Purchase (P): 2,871,287 @ $1.01 | EDGAR |
| 2022-08-05 | 4 | Clene Inc. (CLNN) | Grant/award (A): 6,717 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Clene Inc. (CLNN) | Purchase (P): 75,000 @ $2.50 · Purchase (P): 74,610 @ $2.51 | EDGAR |
| 2022-06-16 | 4 | Clene Inc. (CLNN) | Purchase (P): 51,011 @ $2.66 · Purchase (P): 45,000 @ $2.66 | EDGAR |
| 2022-06-14 | 4 | Clene Inc. (CLNN) | Purchase (P): 55,000 @ $3.06 | EDGAR |
| 2022-06-07 | 4 | Clene Inc. (CLNN) | Purchase (P): 10,000 @ $2.46 · Purchase (P): 50,670 @ $2.57 | EDGAR |
| 2022-05-27 | 4 | Clene Inc. (CLNN) | Purchase (P): 35,000 @ $2.27 | EDGAR |
| 2022-05-18 | 4 | Clene Inc. (CLNN) | Purchase (P): 181,818 @ $2.20 | EDGAR |
| 2022-05-06 | 4 | Clene Inc. (CLNN) | Grant/award (A): 8,920 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-04-21 | 4 | Clene Inc. (CLNN) | Purchase (P): 132,891 @ $3.01 | EDGAR |
| 2022-03-30 | 4 | Clene Inc. (CLNN) | Purchase (P): 10,000 @ $3.10 · Purchase (P): 8,648 @ $3.23 | EDGAR |
| 2022-03-25 | 4 | Clene Inc. (CLNN) | Purchase (P): 20,000 @ $2.94 · Purchase (P): 20,000 @ $2.99 | EDGAR |
| 2022-03-22 | 4 | Clene Inc. (CLNN) | Purchase (P): 20,000 @ $2.79 · Purchase (P): 35,000 @ $2.90 | EDGAR |
| 2022-03-04 | 4 | U.S. WELL SERVICES, INC. (USWS) | Grant/award (A): 697,674 (derivative) | EDGAR |
| 2022-02-04 | 4 | Clene Inc. (CLNN) | Grant/award (A): 9,701 (derivative) @ $0 | EDGAR |
| 2022-02-02 | 4 | Clene Inc. (CLNN) | Purchase (P): 101,352 @ $2.96 | EDGAR |
| 2021-12-10 | 4 | Clene Inc. (CLNN) | Purchase (P): 5,000 @ $4.93 · Purchase (P): 40,000 @ $5 · Purchase (P): 15,000 @ $4.87 | EDGAR |
| 2021-12-08 | 4 | Clene Inc. (CLNN) | Option exercise/expiry (X): 12,500 @ $0.01 · Option exercise/expiry (X): 50,000 @ $0.01 · Option exercise/expiry (X): 12,500 (derivative) @ $0 · Option exercise/expiry (X): 50,000 (derivative) @ $0 | EDGAR |
| 2021-11-17 | 4 | Clene Inc. (CLNN) | Purchase (P): 20,000 @ $5.26 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1251956 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs